Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

AdGene Biosciences

Tracked across 1 events · 9 articles · First seen Sep 10, 2026 · Last active Sep 10, 2026

Sentiment
15
Attention
1
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
1 15
Tech
AdGene Biosciences, a clinical-stage next-generation vaccine platform company based in Delft, Netherlands, announced on September 10, 2026 the publication of a new White Paper titled Boosting mRNA: Mucosal Immunity and a Platform Beyond It. The…
Impact: AdJane is the sole protagonist of the event, publishing the White Paper and promoting its Nm-nOMV mucosal booster platform. The disclosure could support its partnering and valuation narrative, though it remains clinical-stage with no approved product.
Sep 10, 2026 · 9 articles
ERGEN INTELLIGENCE
Track AdGene Biosciences live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.